Unknown

Dataset Information

0

Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial.


ABSTRACT:

Objective

To compare New Zealand medical grade kanuka honey with topical aciclovir for the treatment of herpes simplex labialis.

Design

Prospective parallel randomised controlled open-label superiority trial.

Setting

76 community pharmacies across New Zealand between 10 September 2015 and 13 December 2017.

Participants

952 adults randomised within the first 72?hours of a herpes simplex labialis episode.

Interventions

Random assignment 1:1 to either 5% aciclovir cream or medical grade kanuka honey (90%)/glycerine (10%) cream, both applied five times daily.

Outcome measures

The primary outcome was time from randomisation to return to normal skin (stage 7). Secondary outcomes included time from randomisation to stage 4 (open wound), time from stage 4 to 7, maximal pain, time to pain resolution and treatment acceptability.

Results

Primary outcome variable: Kaplan-Meier-based estimates (95%?CI) for the median time in days for return to normal skin were 8 (8 to 9) days for aciclovir and 9 (8 to 9) for honey; HR (95%?CI) 1.06 (0.92 to 1.22), p=0.56. There were no statistically significant differences between treatments for all secondary outcome variables. No related serious adverse events were reported.

Conclusion

There was no evidence of a difference in efficacy between topical medical grade kanuka honey and 5% aciclovir in the pharmacy-based treatment of herpes simplex labialis.

Trial registration number

ACTRN12615000648527;Post-results.

SUBMITTER: Semprini A 

PROVIDER: S-EPMC6530412 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial.

Semprini Alex A   Singer Joseph J   Braithwaite Irene I   Shortt Nick N   Thayabaran Darmiga D   McConnell Melanie M   Weatherall Mark M   Beasley Richard R  

BMJ open 20190514 5


<h4>Objective</h4>To compare New Zealand medical grade kanuka honey with topical aciclovir for the treatment of herpes simplex labialis.<h4>Design</h4>Prospective parallel randomised controlled open-label superiority trial.<h4>Setting</h4>76 community pharmacies across New Zealand between 10 September 2015 and 13 December 2017.<h4>Participants</h4>952 adults randomised within the first 72 hours of a herpes simplex labialis episode.<h4>Interventions</h4>Random assignment 1:1 to either 5% aciclovi  ...[more]

Similar Datasets

| S-EPMC5724166 | biostudies-literature
| S-EPMC6497618 | biostudies-literature
| S-EPMC7045020 | biostudies-literature
| S-EPMC6461191 | biostudies-literature
| S-EPMC10500555 | biostudies-literature
| S-EPMC4947914 | biostudies-literature
| S-EPMC2650104 | biostudies-literature
| S-EPMC7650106 | biostudies-literature
| S-EPMC3420068 | biostudies-literature
| S-EPMC3203230 | biostudies-literature